CNBC's Jim Cramer on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will change companies, especially ones that sell junk food.on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will affect the stock of companies like
Walmart said last week it is seeing a"slight change" in food-shopping habits, some of which may be due to customers buying less while using appetite-suppressing medications like diabetes drugs Mounjaro or Wegovy,
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
Jim Cramer's top 10 things to watch in the stock market MondayThe Dow, S&P 500 and Nasdaq were lower Monday after Hamas conducted a surprise attack on Israel.
더 많은 것을 읽으십시오 »
Jim Cramer's top 10 things to watch in the stock market TuesdayWall Street stabilizes: The Dow, the S&P 500 and the Nasdaq little changed early Tuesday.
더 많은 것을 읽으십시오 »
Jim Cramer explains why the Israel-Hamas war may not steer Monday's market actionCNBC’s Jim Cramer suggested the deadly conflict between Israel and Hamas may not be the driving force in Monday’s market action.
더 많은 것을 읽으십시오 »
Jim Cramer sees a bull market in cybersecurityCNBC’s Jim Cramer said demand for cybersecurity is high, indicating a potential bull market for the sector.
더 많은 것을 읽으십시오 »